These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25324611)

  • 1. Proper use of clozapine: experiences in China.
    Wang C; Li L
    Shanghai Arch Psychiatry; 2012 Apr; 24(2):108-9. PubMed ID: 25324611
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine in China.
    Tang YL; Mao PX; Jiang F; Chen Q; Wang CY; Cai ZJ; Mitchell PB
    Pharmacopsychiatry; 2008 Jan; 41(1):1-9. PubMed ID: 18203045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of clozapine for the treatment of schizophrenia: findings of the 2006 research on the china psychotropic prescription studies.
    Si TM; Zhang YS; Shu L; Li KQ; Liu XH; Mei QY; Wang GH; Bai PS; Ji LP; Cheng XS; Ma C; Shi JG; Zhang HY; Ma H; Yu X
    Clin Psychopharmacol Neurosci; 2012 Aug; 10(2):99-104. PubMed ID: 23430459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).
    Li Q; Xiang YT; Su YA; Shu L; Yu X; Correll CU; Ungvari GS; Chiu HF; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM; Kane JM
    Schizophr Res; 2015 Oct; 168(1-2):523-9. PubMed ID: 26277534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoperfusion in the treatment of acute clozapine intoxication in China.
    He JL; Xiang YT; Li WB; Cai ZJ; Ungvari GS
    J Clin Psychopharmacol; 2007 Dec; 27(6):667-71. PubMed ID: 18004134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Treatment Strategies of Clozapine for Refractory Schizophrenia.
    Li YY; Zhang YS; Wang J; Li KQ; Wang HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Dec; 38(6):666-678. PubMed ID: 28065233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clozapine in nail and hair of psychiatric patients determined with LC-MS/MS.
    Chen H; Xiang P; Sun QR; Shen M
    Yao Xue Xue Bao; 2012 Sep; 47(9):1193-9. PubMed ID: 23227550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences of women in secure care who have been prescribed clozapine for borderline personality disorder.
    Dickens GL; Frogley C; Mason F; Anagnostakis K; Picchioni MM
    Borderline Personal Disord Emot Dysregul; 2016; 3():12. PubMed ID: 27761261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramuscular clozapine in the acute medical hospital: Experiences from a liaison psychiatry team.
    Gee S; McMullen I; Wyke C; Yeoh SY; Taylor D
    SAGE Open Med Case Rep; 2021; 9():2050313X211004796. PubMed ID: 34094561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation and plasma clozapine concentrations in Chinese patients with schizophrenia.
    Chong SA; Tan CH; Khoo YM; Lee HS; Wong KE; Ngui F; Winslow M
    Ther Drug Monit; 1997 Apr; 19(2):219-23. PubMed ID: 9108654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bioequivalence between generic and brand-name clozapine in Chinese schizophrenic patients: A randomized, two-period, crossover study.
    Yang X; Yan Q; Yang L; Li J; Fan X; Chen J; Wu H; Cai H; Zhu R; Fang P
    Int J Clin Pharmacol Ther; 2021 Aug; 59(8):578-584. PubMed ID: 34142950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial.
    Girgis RR; Phillips MR; Li X; Li K; Jiang H; Wu C; Duan N; Niu Y; Lieberman JA
    Br J Psychiatry; 2011 Oct; 199(4):281-8. PubMed ID: 21292928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design.
    Li X; Guo X; Fan X; Feng T; Wang C; Yao Z; Xu X; Chen Z; Wang H; Xie S; He J; Zhuo K; Xiang Q; Cen H; Wang J; Smith RC; Jin H; Keshavan MS; Marder SR; Davis JM; Jiang K; Xu Y; Liu D
    Schizophr Res; 2021 Apr; 230():87-94. PubMed ID: 33279374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of prohibiting outside food during COVID-19 pandemic on the body weight of schizophrenic patients taking olanzapine or clozapine: a retrospective self-controlled study.
    Zhang C; Wang X; Hu C; Ding W; Li H; Wu M; Hu M; Wang Q; Sun X
    Ann Palliat Med; 2021 May; 10(5):5010-5016. PubMed ID: 33894724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective experiences of clozapine treatment by patients with chronic schizophrenia.
    Waserman J; Criollo M
    Psychiatr Serv; 2000 May; 51(5):666-8. PubMed ID: 10783189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the use of clozapine in individuals with developmental disabilities.
    Sabaawi M; Singh NN; de Leon J
    Res Dev Disabil; 2006; 27(3):309-36. PubMed ID: 16040229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of subjective experiences, effects and overall satisfaction with clozapine treatment in a UK forensic service.
    Qurashi I; Stephenson P; Chu S; Duffy C; Husain N; Chaudhry I
    Ther Adv Psychopharmacol; 2015 Jun; 5(3):146-50. PubMed ID: 26199716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sector user and provider perceptions on experiences of shared-care clozapine: a qualitative study.
    Sowerby C; Taylor D
    BMJ Open; 2017 Sep; 7(9):e017183. PubMed ID: 28963298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis.
    Siskind DJ; Harris M; Phillipou A; Morgan VA; Waterreus A; Galletly C; Carr VJ; Harvey C; Castle D
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):325-337. PubMed ID: 27426892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capillary compared to venous blood sampling in clozapine treatment: patients׳ and healthcare practitioners׳ experiences with a point-of-care device.
    Bogers JP; Bui H; Herruer M; Cohen D
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):319-24. PubMed ID: 25548103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.